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miRNAs were downregulated across levels of LTC wine 
consumption.
Conclusions Our results suggest that wine influences 
miRNA expression in rectal cancer, supporting the 
hypothesis that components in alcohol influence miRNA 
expression.
Keywords MiRNA · Rectal · Colorectal · Cancer · 
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Background
Alcohol intake has been associated with all-cause mor-
tality (ACM) as well as with several diseases, including 
certain types of cancer, cardiovascular disease, diabetes 
mellitus, liver diseases, and obesity [1–5]. Furthermore, 
specific types of alcohol have been shown to influence 
disease risk uniquely [6, 7]. Some studies have shown an 
increase in ACM at both high and low levels of intake 
and others have shown that moderate alcohol consump-
tion does not increase disease risk [3, 8]. Given alcoholic 
beverage-specific associations and the j-shaped curve asso-
ciated with ACM, multiple biological mechanisms may 
operate to influence risk of disease and death from alcohol 
consumption.
Alcohol consumption has been shown to incite inflam-
matory responses, and prolonged consumption can induce 
systemic inflammation [5]. Lipopolysaccharides (LPS) 
can become circulated systemically in individuals who 
consume large amounts of alcohol, as alcohol increases 
gut membrane permeability [5, 9]. When these antigens 
reach the liver, pro-inflammatory cytokines such as TNF-
α, IL-1, and IL-6 are released, creating a potential sys-
temic inflammatory reaction [10]; LPS has been linked to 
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Purpose Alcohol consumption has been purported to 
influence many diseases. MicroRNAs (miRNAs) may be 
influenced by compounds found in alcohol. In this investi-
gation, we test the hypothesis that total alcohol, beer, wine, 
and hard liquor influence miRNA expression.
Methods We studied 1447 colorectal (CR) cancer cases 
with normal CR mucosa and carcinoma miRNA expres-
sion data along with alcohol consumption data. We ana-
lyzed long-term and long-term and current (LTC) alcohol 
use for beer, liquor, and wine with miRNA expression 
between paired carcinoma and normal colon and rectal tis-
sues, adjusting for multiple comparisons using the positive 
false discovery rate q-value. MiRNAs associated signifi-
cantly with alcohol were examined with all-cause mortality 
(ACM). MiRNAs associated significantly with ACM were 
examined with RNA-Seq data.
Results Expression of 84 miRNAs was associated signifi-
cantly with LTC wine use in normal rectal mucosa. Higher 
expression of two of these miRNAs significantly wors-
ened ACM: hsa-miR-210 (Hazard Ratio [HR] 1.12, 95% 
CI (1.03, 1.21), p-value = 0.004), and hsa-miR-92a-1-5p 
(HR 1.20, 95% CI (1.04, 1.38), p-value = 0.013). These 
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liver metastasis in colorectal cancer (CRC) as a result of 
this increased inflammation [11]. Chronic inflammation 
is known to be a salient process contributing to the devel-
opment and progression of cancer [12], and alcohol con-
sumption has been shown to increase risk of CRC com-
pared to non-drinkers [13]; inflammation due to alcohol 
consumption may therefore contribute to the pathogen-
esis of some diseases, such as CRC. Additionally, alcohol 
has been assessed as a component of DNA methylation 
pathways and it has been hypothesized that alcohol influ-
ences cancer risk by influencing these pathways [14, 15].
In addition to these broad mechanisms associated 
with alcohol intake, types of alcoholic beverages con-
tain specific components that may influence disease risk. 
For instance, purines, found most abundantly in beer and 
in liquor to a lesser extent, may have pro-inflammatory 
effects through increased serum uric acid production [16, 
17]. Polyphenols in wine, such as resveratrol, may have 
anti-inflammatory properties that reduce risk of various 
diseases [18, 19]. Polyphenols are known to have multi-
target effects and influence many pathways, including 
anti-inflammatory responses, anti-proliferation, and anti-
oxidation [20].
MiRNAs are non-coding RNA molecules, approxi-
mately 22 nucleotides long [21], which are endogenously 
expressed and serve as mRNA repressors, either through 
mRNA degradation or translation inhibition [22, 23]. 
MiRNAs have been shown to target thousands of diverse 
mRNAs [24], and as such they have been implicated as 
regulators of a multitude of biological responses includ-
ing apoptosis, cell differentiation, proliferation, and 
innate and acquired immunity [25]. Additionally, miRNA 
dysregulation has been associated with cancer and auto-
immune diseases, disease states influenced by chronic 
inflammation [26]. MiRNAs are purported to be regu-
lated themselves by certain exogenous dietary factors, 
such as vitamins, fatty acids, and polyphenols, which are 
present in many foods, including wine [20, 27].
In this study, we analyzed total alcohol consumption 
as well as intake of specific types of alcohol includ-
ing beer, liquor and wine, with miRNA expression. We 
assessed associations between alcoholic beverages and 
miRNA expression in normal colorectal mucosa (NCRM) 
and with differential miRNA expression between paired 
carcinoma and normal mucosa, analyzing colon and rec-
tal cancers separately. We hypothesize that alcohol con-
sumption will be associated with altered miRNA expres-
sion and that type of alcoholic beverage, i.e., wine, beer, 
and liquor, may have unique associations with normal 
and/or differential miRNA expression due to differ-




Data come from participants in the population-based Diet, 
Activity, and Lifestyle study that were recruited from 
Utah or the Kaiser Permanente Medical Care Program of 
Northern California (KPMCP). Colon cancer cases were 
identified as having a primary adenocarcinoma diagnosed 
between 1 October 1991 and 30 September 1994, while 
rectal cancer cases were diagnosed between May 1997 and 
May 2001. Eligible cases were between 30 and 79 years of 
age at diagnosis, currently living in the study area, spoke 
English and were able to complete an interview, and had 
no prior history of CRC, Crohn’s disease, ulcerative colitis, 
or known familial adenomatous polyposis. More detailed 
descriptions of proportion of included and excluded cases 
for colon cancer [28] and rectal cancer [29] may be found 
in our previous works. This study was approved by the 
Institutional Review Board at the University of Utah; all 
participants signed an informed consent form.
Alcohol data
Data were collected by trained and certified interviewers 
using laptop computers; all interviews were audio-taped 
as previously described and reviewed for quality control 
purposes [30]. The study referent period was 2 years prior 
to diagnosis for cases. Information was collected on type, 
amount, and duration of alcohol consumption, which was 
defined in terms of liquor, including whiskey, rum, gin, 
vodka, tequila, liqueurs, etc., beer, including malt liquor 
and non-alcoholic beers, and wine, including champagne, 
sherry, and wine cooler beverages. Alcohol consumed was 
measured in number of drinks consumed, as measured by 
12-ounces (oz.) for beer, 4  oz. for wine, and 1.5  oz. for 
liquor, per week or month and respondents must have con-
sumed on average at least one beverage a month to be con-
sidered a consumer. Diet history on what cases typically 
consumed was collected, including alcohol consumption 
for weekdays and weekend days as well as type, amount, 
and frequency of alcohol consumed. Data were collected 
for the referent year, and 10 and 20 years prior. Long-term 
(LT) alcohol consumption was defined as intake during 10 
and 20 years prior to diagnosis, while incorporating current 
alcohol intake during the referent period with that of 10 
and 20 years ago was defined as long-term current (LTC).
MiRNA processing
A pathologist determined carcinoma and normal mucosa 
sections on slides from formalin-fixed paraffin embedded 
tissues stained with hematoxylin and eosin; subsequent 
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cuts from the tissue block stained in aniline blue were 
then appropriately sectioned according to this delineation. 
RNA was extracted and processed as previously described 
[31]. 100 ng total RNA was labeled with Cy3 and hybrid-
ized to Agilent Human miRNA Microarrays V19.0 and 
were scanned on an Agilent SureScan microarray scanner 
model G2600D using Agilent Feature Extract software 
v.11.5.1.1. Data were required to pass stringent QC param-
eters established by Agilent that included tests for exces-
sive background fluorescence, excessive variation among 
probe sequence replicates on the array, and measures of the 
total gene signal on the array to assess low signal. Samples 
that failed to meet QC standards were repeated; samples 
failing QC assessment a second time were deemed to be of 
poor quality and were excluded from down-stream analy-
sis. Thirteen samples, eight carcinoma, and five, matched 
normal, which were run over the course of the study 
were repeated to test for potential changes and bias in the 
microarray platform. The Agilent platform was found to 
be highly reliable (r = 0.98) in measuring miRNA expres-
sion in repeated samples and to have reasonable agreement 
with NanoString [32] as well as excellent agreement with 
qRT-PCR [33]. For unpaired samples due to missing nor-
mal scans, we imputed values whenever possible for nor-
mal mucosa as previously described [34]; this method has 
yielded results with high accuracy. In order to minimize 
differences that could be attributed to the array, amount of 
RNA, location on array, or other factors that could errone-
ously influence expression, total gene signal was normal-
ized by multiplying each sample by a scaling factor which 
was the median of the 75th percentiles of all the samples 
divided by the 75th percentile of each individual sample 
[35]. This scaling factor was implemented using SAS 9.4.
RNA‑seq data
Normal CR RNA-Seq was available for 183 subjects for 
which alcohol data were available. These samples were 
taken from the study subjects used for miRNA analysis 
and were extracted, isolated, and purified as previously 
described [31]. RNA library construction was done with 
the Illumina TruSeq Stranded Total RNA Sample Prepa-
ration Kit with Ribo-Zero. Agencount AMPure XP beads 
were used to purify amplified cDNA. A detailed descrip-
tion of the methods can be found in our previous work [36]. 
Illumina TruSeq v3 single-read flow cell and a 50 cycle sin-
gle-read sequence run was performed on an Illumina HiSeq 
instrument. Reads were aligned to a sequence database 
containing the human genome (build GRCh37/hg19, Feb-
ruary 2009 from genome.ucsc.edu) and alignment was per-
formed using novoalign v2.08.01. Total gene counts were 
calculated using coordinates obtained from http://genome.
ucsc.edu. We dropped genes that were not expressed in our 
data or for which the expression was missing for the major-
ity of samples [36].
Statistical analysis
Our sample consisted of 2,943 miRNA tissue samples: 
1,496 carcinoma tissue, and 1,447 normal CR mucosa. 
Including the imputed data, there were 1,446 subjects with 
both carcinoma and paired normal CR mucosa miRNA 
samples available for analyzing differential expression 
between carcinoma and normal CR mucosa, and 1,447 sub-
jects available for analyzing normal CR mucosa miRNA 
expression. We included only the miRNAs in which at least 
20% of the samples had some level of detectable expres-
sion in the tissue(s) of interest. We stratified the data by 
colon vs. rectal cancer, and the number of included miR-
NAs varied from 766 to 817. We examined eight alcohol 
variables: LT total alcohol use, LTC total alcohol use, LT 
beer use, LTC beer use, LT wine use, LTC wine use, LT 
liquor use, and LTC liquor use. These variables were used 
to determine if there was an association between total alco-
hol and specific type of alcohol and miRNA expression in 
both normal colonic or rectal mucosa and for the difference 
in expression between carcinoma tissue and normal colonic 
or rectal mucosa. We fit a least-squares linear regression 
model to the log base two transformed miRNA expression 
levels and adjusting for age at diagnosis, study center, sex, 
and current cigarette smoking (defined as smoking dur-
ing the referent period). p-values were generated using the 
bootstrap method by creating a distribution of 10,000  F 
statistics derived by resampling the residuals from the null 
hypothesis model of no association between the alcohol 
variables and the miRNAs [37], using the boot package in 
R. Associations were considered significant if the positive 
false discovery rate, also known as a q-value, was less than 
0.1 [38]. We transformed the miRNAs to standard normal 
to calculate standardized the regression slopes in order to 
compare the results across the miRNA and lifestyle fac-
tors and present the trend of the miRNA expression across 
the levels of each alcohol variable. Alcohol consumption 
levels were classified as ‘none’ if subjects consumed <1 
drink per month on the long-term alcohol intake question-
naire and no alcoholic beverages reported on the food his-
tory questionnaire, ‘moderate’ for males who consumed 
>0–<20 mg/day and females who consumed >0–<10 mg/
day, and ‘high’ for males consuming ≥ 20 g/day and females 
consuming ≥ 10 g/day.
We analyzed expression levels of miRNAs that were 
significantly associated with alcohol variables with ACM. 
Using a Cox-Proportional Hazard Model in the R package 
survival, we calculated p-values based upon 10,000 per-
mutations of the likelihood ratio test adjusting for age, sex, 
center, and AJCC stage. Survival time was calculated as the 
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time between diagnosis, and death or lost to follow-up. We 
report the interquartile range of the miRNA expression and 
hazard ratios (HR) and 95% confidence intervals (CI).
We tested associations between miRNAs found to 
be associated with alcohol consumption and ACM with 
mRNA expression in NCRM, using the bootstrap method 
described above.
Bioinformatics
QIAGEN Ingenuity Pathway Analysis (IPA http://www.qia-
gen.com/ingenuity) was utilized to perform pathway analy-
sis on mRNAs associated significantly with hsa-miR-210 in 
NCRM. We performed a core analysis, including direct and 
indirect relationships, using the ingenuity knowledge base. 
We restricted to experimentally verified findings and mam-
malian species, and considered all data sources, tissues, 
and mutations.
Results
The study population consisted of 892 colon cancer cases 
and 555 rectal cancer cases; 54% of cases were male and 
46% were female for colon cases, and 57% of cases were 
male and 43% were female for rectal cases (Table 1). The 
average age at diagnosis was 64.7 years for colon cancer 
subjects and 61.8 years for rectal cancer subjects. Eighty-
six percent of colon cases and 89 percent of rectal cases did 
not have a family history of CRC, while approximately 14 
percent and 11 percent, respectively, did.
Eighty-four miRNAs were associated with LTC wine 
consumption in normal mucosa in rectal cancer subjects 
(Table  2) after adjusting for cigarette smoking, age, sex, 
and study center. Five of these miRNAs were upregulated 
and 79 were downregulated across levels of LTC wine 
consumption. We analyzed these 84 miRNAs that were 
different by level of LTC wine consumption with ACM. 
Higher expression of two of these miRNAs in NCRM 
was associated significantly with ACM: hsa-miR-210 (HR 
1.12, 95% CI (1.03, 1.21), p-value = 0.004), and hsa-miR-
92a-1-5p (HR 1.20, 95% CI (1.04, 1.38), p-value = 0.013) 
(data shown in Supplemental Table 1). We tested associa-
tions between these two miRNAs and mRNAs expressed in 
NCRM. No mRNAs were associated significantly with hsa-
miR-92a-1-5p; 5597 mRNAs associated with hsa-miR-210 
when a q-value of <0.05 was applied. Of these, 3169 had 
a fold change between carcinoma and NCRM of ≥ 1.50 
or ≤ 0.67, and were used as input to IPA. The top net-
works are shown in Fig. 1. The majority of these mRNAs 
were directly associated with hsa-miR-210. Network 1, 
centered on TP53, has DNA Replication, Recombina-
tion, and Repair, Developmental Disorder, and Endocrine 
Systems Disorder as its top diseases and networks. Net-
work 2, centered on SMARCA4, regulates Cellular Devel-
opment, Hereditary Disorder, and Lipid Metabolism. 
Network 3, centered on CCND1, regulates Cell Cycle, Cel-
lular Assembly and Organization, and DNA Replication, 
Table 1  Study sample descriptions
Colon Rectal
N/Mean (%/SD) N/Mean (%/SD)
Age at diagnosis 64.7 (9.5) 61.8 (10.8)
 Sex
  Male 485 (54.4) 316 (56.9)
  Female 407 (45.6) 239 (43.1)
 Center
  Kaiser 626 (70.2) 340 (61.3)
  Utah 266 (29.8) 215 (38.7)
 Family history of colorectal cancer
  No 770 (86.3) 493 (89.0)
  Yes 122 (13.7) 61 (11.0)
 Long-term alcohol use
  None 390 (43.7) 239 (43.2)
  Moderate 288 (32.3) 168 (30.4)
  High 214 (24.0) 146 (26.4)
 Long-term & current alcohol use
  None 347 (38.9) 213 (38.5)
  Moderate 366 (41.0) 200 (36.2)
  High 179 (20.1) 140 (25.3)
 Long-term beer use
  None 565 (63.3) 329 (59.7)
  Moderate 171 (19.2) 92 (16.7)
  High 156 (17.5) 130 (23.6)
 Long-term & current beer use
  None 538 (60.3) 311 (56.3)
  Moderate 222 (24.9) 111 (20.1)
  High 132 (14.8) 130 (23.6)
 Long-term wine use
  None 588 (65.9) 365 (66.1)
  Moderate 136 (15.2) 97 (17.6)
  High 168 (18.8) 90 (16.3)
 Long-term & current wine use
  None 519 (58.2) 340 (61.6)
  Moderate 236 (26.5) 108 (19.6)
  High 137 (15.4) 104 (18.8)
 Long-term liquor use
  None 513 (57.5) 339 (61.6)
  Moderate 218 (24.4) 133 (24.2)
  High 161 (18.0) 78 (14.2)
 Long-term & current liquor use
  None 490 (54.9) 330 (59.8)
  Moderate 244 (27.4) 141 (25.5)
  High 158 (17.7) 81 (14.7)
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Table 2  MicroRNA expression 
associated with LTC wine 
consumption in normal rectal 
mucosa
miRNA Mean miRNA expression Betaa p-value q-value
None Moderate High
Tumorb Normal Tumorb Normal Tumorb Normal
hsa-miR-100-5p 9.77 10.45 10.67 9.70 7.46 6.67 −0.23 <0.0001 0.0808
hsa-miR-106b-5p 12.95 3.36 11.45 3.46 13.06 2.48 −0.19 0.0031 0.0880
hsa-miR-10b-5p 8.95 11.23 8.84 9.68 8.12 8.43 −0.17 0.0096 0.0915
hsa-miR-1203 1.70 2.41 1.96 2.45 2.11 2.25 −0.18 0.0052 0.0915
hsa-miR-127-3p 2.22 0.93 2.47 0.95 2.16 0.22 −0.13 0.0110 0.0915
hsa-miR-1295b-3p 2.63 2.61 3.05 2.46 3.09 2.34 −0.15 0.0213 0.0980
hsa-miR-130a-3p 5.58 4.26 6.09 4.22 5.49 2.67 −0.16 0.0018 0.0808
hsa-miR-132-3p 0.94 1.25 0.97 1.33 1.61 0.35 −0.15 0.0083 0.0915
hsa-miR-133b 1.17 6.90 1.67 6.55 1.30 4.75 −0.21 0.0002 0.0808
hsa-miR-143-3p 5.29 8.36 6.43 7.80 5.46 6.38 −0.16 0.0139 0.0923
hsa-miR-145-5p 127.50 269.68 145.98 249.57 108.42 201.84 −0.15 0.0178 0.0944
hsa-miR-151a-3p 4.31 1.07 3.81 0.98 4.42 0.59 −0.14 0.0148 0.0923
hsa-miR-15a-5p 6.31 3.18 5.31 3.07 6.66 2.05 −0.21 0.0007 0.0808
hsa-miR-15b-5p 35.15 25.56 29.66 22.44 30.11 19.68 −0.17 0.0102 0.0915
hsa-miR-17-5p 56.07 13.55 47.34 13.08 51.50 11.61 −0.16 0.0222 0.0983
hsa-miR-181a-5p 35.81 25.17 33.88 24.18 30.44 22.21 −0.14 0.0170 0.0944
hsa-miR-184 2.27 2.34 2.39 2.65 2.45 1.86 −0.15 0.0120 0.0923
hsa-miR-193b-3p 10.19 6.06 9.51 5.72 7.59 4.45 −0.15 0.0089 0.0915
hsa-miR-195-5p 3.08 10.86 3.12 9.73 2.95 7.79 −0.20 0.0025 0.0808
hsa-miR-199a-3p 41.35 19.32 40.70 17.58 32.62 14.29 −0.15 0.0204 0.0979
hsa-miR-199a-5p 18.56 7.90 18.42 6.88 14.04 5.28 −0.20 0.0006 0.0808
hsa-miR-199b-5p 3.62 1.17 3.90 0.86 3.70 0.50 −0.17 0.0094 0.0915
hsa-miR-204-3p 0.48 1.00 0.80 0.87 0.72 0.94 −0.16 0.0149 0.0923
hsa-miR-210 22.73 16.21 20.75 14.11 18.23 15.48 −0.06 0.0084 0.0915
hsa-miR-2117 1.45 3.23 1.60 3.10 1.76 2.94 −0.17 0.0087 0.0915
hsa-miR-222-3p 16.17 9.19 15.42 8.63 14.94 7.72 −0.16 0.0113 0.0915
hsa-miR-2278 1.72 1.91 1.61 1.83 1.87 1.80 −0.11 0.0211 0.0980
hsa-miR-25-3p 28.71 11.29 23.88 10.05 26.41 8.62 −0.18 0.0056 0.0915
hsa-miR-27b-3p 32.42 24.57 30.10 22.50 27.54 18.91 −0.16 0.0177 0.0944
hsa-miR-28-5p 1.34 1.87 1.39 1.52 1.43 1.10 −0.16 0.0132 0.0923
hsa-miR-302c-5p 2.02 1.65 2.10 1.38 2.54 1.16 −0.18 0.0070 0.0915
hsa-miR-30a-5p 1.51 3.66 1.61 3.06 1.80 2.18 −0.21 0.0008 0.0808
hsa-miR-30c-5p 7.93 10.29 6.52 9.13 7.10 7.63 −0.16 0.0157 0.0923
hsa-miR-30e-5p 2.78 3.12 2.23 2.79 3.15 2.35 −0.17 0.0115 0.0915
hsa-miR-3164 1.20 2.02 1.70 1.89 1.84 1.62 −0.17 0.0097 0.0915
hsa-miR-3187-5p 3.49 2.41 3.95 2.27 4.27 1.99 −0.18 0.0073 0.0915
hsa-miR-324-5p 4.22 1.73 3.05 1.66 4.34 0.96 −0.17 0.0039 0.0915
hsa-miR-3609 2.56 1.79 2.28 1.94 2.92 1.62 −0.13 0.0195 0.0964
hsa-miR-3616-3p 3.32 2.69 3.26 2.69 4.17 1.95 −0.15 0.0113 0.0915
hsa-miR-3617-5p 3.62 4.04 4.11 3.92 4.22 3.26 −0.15 0.0200 0.0976
hsa-miR-3620-3p 7.21 8.12 7.64 8.91 6.86 8.33 0.08 0.0102 0.0915
hsa-miR-362-5p 2.96 0.51 2.33 0.46 3.34 0.13 −0.17 0.0092 0.0915
hsa-miR-365a-3p 8.13 3.95 7.12 3.72 7.15 2.72 −0.13 0.0133 0.0923
hsa-miR-3680-3p 6.68 6.12 7.01 6.43 7.30 5.53 −0.13 0.0157 0.0923
hsa-miR-378d 0.22 1.58 0.20 1.36 0.29 1.36 −0.17 0.0081 0.0915
hsa-miR-378g 1.11 1.87 1.28 1.76 1.67 1.45 −0.19 0.0045 0.0915
hsa-miR-3922-5p 1.45 1.19 1.72 1.34 1.67 1.08 −0.14 0.0229 0.0998
hsa-miR-3976 2.39 0.95 2.54 1.04 2.59 0.59 −0.17 0.0022 0.0808
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Recombination and Repair. At the center of networks 1 and 
3 are TP53 and SMARCA4 respectively, which are tran-
scription factors (TFs), and at the center of network 2 is 
CCND1, which encodes for the Cyclin-D1 protein, a key 
regulator of the cell cycle.
No other alcohol variables, including total alcohol 
consumption, beer consumption, and hard liquor con-
sumption were associated with miRNA expression level. 
While hard liquor was associated with expression levels 
of 21 miRNAs, none of these remained significant after 
adjusting for cigarette smoking status.
Table 2  (continued) miRNA Mean miRNA expression Betaa p-value q-value
None Moderate High
Tumorb Normal Tumorb Normal Tumorb Normal
hsa-miR-425-3p 12.43 14.70 12.66 15.65 11.95 15.83 0.15 0.0217 0.0980
hsa-miR-425-5p 11.55 6.17 9.75 5.17 10.03 4.54 −0.17 0.0053 0.0915
hsa-miR-4280 3.45 2.99 3.82 2.94 4.50 2.94 −0.16 0.0190 0.0952
hsa-miR-4296 1.72 1.13 2.07 1.00 1.94 0.94 −0.16 0.0177 0.0944
hsa-miR-432-5p 2.55 2.15 2.65 2.10 2.74 1.72 −0.16 0.0103 0.0915
hsa-miR-4450 3.83 3.40 4.29 2.97 4.44 2.89 −0.20 0.0018 0.0808
hsa-miR-4469 1.32 2.22 1.52 1.87 1.36 1.88 −0.16 0.0085 0.0915
hsa-miR-4479 1.90 2.15 2.00 1.98 2.09 1.76 −0.20 0.0024 0.0808
hsa-miR-4657 3.01 1.85 3.29 1.89 3.57 1.51 −0.17 0.0101 0.0915
hsa-miR-4659b-3p 4.25 5.32 4.34 5.05 4.95 4.86 −0.15 0.0223 0.0983
hsa-miR-4660 4.84 4.11 5.24 3.69 5.14 3.44 −0.17 0.0060 0.0915
hsa-miR-4684-3p 1.73 2.14 2.10 2.00 2.26 1.90 −0.17 0.0128 0.0923
hsa-miR-4730 8.99 9.06 7.68 11.03 7.80 7.51 −0.07 0.0151 0.0923
hsa-miR-4748 4.79 4.78 4.96 4.62 5.24 4.19 −0.16 0.0147 0.0923
hsa-miR-484 1.67 1.67 1.36 1.42 2.33 0.92 −0.19 0.0012 0.0808
hsa-miR-497-5p 1.13 5.79 1.17 5.46 1.32 4.14 −0.22 0.0004 0.0808
hsa-miR-5008-3p 1.81 0.79 1.96 0.73 2.19 0.39 −0.14 0.0153 0.0923
hsa-miR-518c-5p 1.57 1.91 1.86 1.92 1.85 1.57 −0.16 0.0137 0.0923
hsa-miR-525-5p 1.68 1.71 1.78 1.33 1.82 1.02 −0.15 0.0206 0.0979
hsa-miR-532-5p 4.79 1.01 3.90 0.72 5.23 0.34 −0.17 0.0081 0.0915
hsa-miR-548aa 1.93 2.14 1.68 2.40 1.72 2.08 0.01 0.0042 0.0915
hsa-miR-548am-5p 0.91 1.12 0.69 1.58 1.06 0.75 −0.09 <0.0001 0.0808
hsa-miR-551b-5p 1.31 0.99 1.56 0.95 1.60 0.85 −0.17 0.0110 0.0915
hsa-miR-566 3.08 3.52 3.56 3.86 3.75 3.12 −0.11 0.0157 0.0923
hsa-miR-5685 0.76 2.23 1.08 2.04 1.22 2.16 −0.16 0.0182 0.0951
hsa-miR-595 5.41 5.68 4.83 5.72 4.25 4.67 −0.05 0.0113 0.0915
hsa-miR-615-3p 1.06 1.09 0.98 1.28 1.22 1.06 −0.02 0.0187 0.0952
hsa-miR-636 8.76 10.83 9.98 11.69 9.10 11.91 0.13 0.0215 0.0980
hsa-miR-6500-3p 3.00 3.37 3.44 3.00 3.92 2.96 −0.16 0.0178 0.0944
hsa-miR-652-3p 1.66 0.81 1.72 0.73 2.06 0.38 −0.16 0.0123 0.0923
hsa-miR-6716-3p 5.22 4.23 4.10 7.60 4.79 3.20 −0.04 0.0166 0.0944
hsa-miR-877-3p 24.17 31.59 26.55 34.59 25.26 34.15 0.13 0.0124 0.0923
hsa-miR-92a-1-5p 0.57 0.78 0.55 0.70 0.82 0.60 −0.16 0.0188 0.0952
hsa-miR-93-5p 37.48 12.83 31.04 11.72 35.90 10.33 −0.17 0.0111 0.0915
hsa-miR-99a-5p 6.48 3.59 8.31 3.05 5.56 1.98 −0.15 0.0063 0.0915
hsa-miR-99b-5p 4.65 4.06 5.00 3.99 3.93 2.99 −0.15 0.0159 0.0923
a Adjusted for age at diagnosis, study center, sex, and current smoking
b Tumor miRNA expression shown for information only; this was not used in the analysis and was not asso-
ciated with alcohol use
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Discussion
Long-term current wine consumption significantly altered 
miRNA expression in normal rectal mucosa (NRM) of 
84 miRNAs. These findings support the hypothesis that 
alcohol consumption is able to influence miRNA expres-
sion. Furthermore, they suggest that different forms of 
alcohol are able to impact miRNA expression in a dis-
tinctive manner, as we only detected associations for LTC 
wine after adjusting for multiple comparisons. Two miR-
NAs associated across LTC wine in NRM, hsa-miR-210 
and hsa-miR-92a-1-5p, also significantly worsened ACM 
when expression levels were higher. Hsa-miR-210 was 
directly associated with expression of a multitude of 
mRNAs in NCRM, suggesting miRNAs that are influ-
enced by wine consumption alter mRNAs in NCRM, and 
this disruption to normal pathways may contribute to a 
variety of disease processes, affecting ACM.
Previously, we reported associations between alcohol 
intake and rectal cancer risk in these subjects, and we did 
not see significant associations for liquor and wine in gen-
eral; however, we found that, in subjects who were non-
users of NSAIDs, high long-term liquor or beer intake 
significantly increased risk of developing rectal cancer 
compared to subjects who did use NSAIDs [39]. This find-
ing suggests that liquor and beer consumption have an 
inherent inflammatory effect that is ameliorated by NSAID 
use. Alcohol metabolism is known to lead to reactive oxy-
gen species production, which may stimulate nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB), 
a pro-inflammatory factor [5]. A German study found that 
not drinking wine recently and over a lifetime significantly 
increased chance of death overall and for CRC specifically 
Fig. 1  IPA top networks generated for mRNAs associated with hsa-miR-210 with a FC of greater than or equal to 1.5 or less than or equal to 
0.67
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compared to subjects who drank ≤ 12 g/day of wine [7]. As 
we saw that NSAIDs moderated risk in liquor users only, 
it is possible that wine consumption does not trigger the 
same inflammatory response that liquor consumption does, 
or instead instigates an anti-inflammatory response. Higher 
beer and liquor intake, but not wine intake, was associ-
ated with greater risk of incidence of gout [40] in a study 
conducted by Choi et al. Gout, an inflammatory disease, is 
generally thought to be preceded by hyperuricemia, a con-
dition tied to alcohol consumption, and Choi et  al. found 
that beer and liquor, but not wine, increased serum uric 
acid levels [16]. Ethanol itself increases serum uric acid, 
through decreased excretion as well as increased produc-
tion, and alcoholic beverages that contain more purines, 
such as beer, which contains high levels of guanosine, and 
liquor to a lesser extent, exacerbate this effect as these mol-
ecules are metabolized into uric acid [16, 41]. As uric acid 
indicates elevated oxidative stress, Choi et  al. proposed 
anti-oxidant non-alcoholic components of wine, such as 
polyphenols, may prevent uric acid levels from rising with 
moderate wine consumption [16].
Resveratrol, an anti-oxidative polyphenol found in 
grapes, has been shown to mitigate many pathological 
responses, including chronic inflammation and cancer [26]. 
One hypothesis as to how resveratrol is able to influence 
so many disease states, and the multitude of biological pro-
cesses involved, is by altering the expression of miRNAs 
[26]. Resveratrol has been linked to the upregulation of 
hsa-miR-663 [26, 42]; however, we did not replicate this 
finding. Seven miRNAs associated across LTC wine con-
sumption in NRM have been previously associated with 
resveratrol presence in human CRC cells in other stud-
ies [20, 43]. Hsa-miR-100-5p, hsa-miR-17-5p, hsa-miR-
181a-5p, hsa-miR-25-3p, and hsa-miR-30e-5p were all 
downregulated with increased LTC wine consumption, and 
were previously shown to have decreased expression with 
the addition of resveratrol to cells [43]. Hsa-miR-30c-5p 
was downregulated in our dataset and hsa-miR-615-3p was 
upregulated between no and moderate LTC wine intake, 
but decreased between moderate and high consumption in 
our data; both hsa-miR-30c-5p and hsa-miR-615-3p were 
shown to increase with resveratrol addition by Tili et  al. 
[43].
Quercetin, another polyphenol found in red wines, influ-
ences miRNA expression [20], and has been studied with 
expression of select miRNAs in mouse models [44], as well 
as in various human cancers [45–47]. In the mouse model, 
mmu-miR-181a, 324-5p, 210, and 99b were upregulated, 
and 30c-1 (stem loop to miR-30c-5p in humans) and 10b 
were downregulated [44] with the addition of quercetin. We 
saw significant downregulation across LTC wine consump-
tion for all six miRNAs. In colon [46] and renal cancers 
[47], quercetin combined with resveratrol and hyperoside 
respectively decreased expression of hsa-miR-27a; we did 
not replicate this finding.
As alcohol is known to influence many disease states [1, 
2], we analyzed the 84 miRNAs associated significantly 
with wine LTC for associations with ACM across colon 
and rectal cases combined. Two miRNAs, hsa-miR-210 
and hsa-miR-92a-1-5p, significantly worsened ACM when 
expression increased in NCRM. These miRNAs were 
downregulated in NRM across LTC wine consumption lev-
els. This finding suggests that moderate to high wine con-
sumption decreases miRNAs that potentially are oncogenic, 
as they are shown to worsen CRC survival with greater 
expression. As these miRNAs were only dysregulated in 
NRM, it is likely that this altered expression disrupts nor-
mal biological pathways, contributing to overall disease 
states and ACM, rather than CRC pathogenesis specifically.
To identify potentially dysregulated pathways, we tested 
associations between mRNAs and hsa-miR-210 and hsa-
miR-92a-1-5p in NCRM. No mRNAs were associated 
significantly with hsa-miR-92a-1-5p; 3169 mRNAs were 
associated with hsa-miR-210 expression when a q-value 
of <0.5 was applied and a fold change restriction of ≥ 1.5 
or <0.67 were applied. Of these, 14 displayed the typical 
inverse relationship of miRNA::mRNA interactions. While 
miRNAs are known to upregulate target gene expres-
sion in certain conditions [48], it is likely external factors 
influence the expression of these genes in concert with 
hsa-miR-210. A multitude of genes upregulate TP53 and 
CCND1; it is therefore possible that one, or a combination, 
of these genes is responsible for the positive beta coeffi-
cient between hsa-miR-210 and these genes. TFs form feed 
forward loops (FFLs) with miRNAs and target genes [49, 
50]. In certain FFLs, a TF will upregulate a miRNA and its 
target gene, creating an ‘incoherent’ FFL. Both SMARCA4 
and TP53 display numerous ‘direct activation’ connections, 
that are either bidirectional or leading away from the center, 
indicating their positive regulatory capacity. Conversely, 
CCND1 is the target of regulation by a larger majority of 
genes in its network. GTF3C4, HOXB13, ATAD2 are TFs 
that may activate CCND1. Given the interconnectedness of 
the networks and the regulatory ability of so many of the 
genes in the network, it is possible other genes, specifically 
TFs, influence the direct association between these mRNAs 
and hsa-miR-210.
Many of the studies cited from the literature used car-
cinoma tissue; we looked at miRNA expression in both 
NCRM and differential miRNA expression, between paired 
carcinoma and NCRM, to determine if alcohol influ-
enced miRNA expression. We did not see any associations 
between alcohol use and differential miRNA expression 
between carcinoma and NCRM; however, we did see that 
LTC wine use influenced the expression of 84 miRNAs 
in NRM only. As these miRNAs were not associated with 
Cancer Causes Control 
1 3
differential expression, we can infer that these miRNAs’ 
expression, while influenced by alcohol consumption, 
does not differ within the individual’s carcinoma and nor-
mal mucosa, and therefore is behaving similarly to carci-
noma tissue miRNA expression reported in other studies. 
As these miRNAs are not differentially expressed, it is 
possible that alcohol use contributes to the global dysreg-
ulation of miRNAs, and is one of many factors influenc-
ing disease progression. As we only see associations with 
LTC wine, it may be the non-alcoholic components unique 
to wine, including phytochemicals, that are responsible for 
the altered expression of these miRNAs. As these data used 
colorectal tissue, other tissue types may have different asso-
ciations with alcoholic beverages and miRNA expression.
Our study has many strengths, including our large sam-
ple size. This enabled us to analyze colon and rectal cases 
separately; as we only detected significant results for NRM 
expression, we may not have found significant results if 
we had combined colon and rectal cancers or examined 
only colon cancer cases. Additionally, we used a micro-
array platform to collect miRNA expression data, which 
enabled us to take a discovery approach. This is valuable, 
as miRNA expression associated with alcohol use has not 
been studied extensively. As we have already stated, this 
method has high reliability, which is another asset, as well 
as good concordance with other methods [32, 33]. Another 
strength of this study is our detailed diet history, which 
enabled us to collect data on specific alcohol consump-
tion. We have shown that liquor and wine were associated 
with different miRNAs, and we would not have been able 
to distinguish these miRNAs otherwise. While we did not 
replicate all of the findings in the literature, it is possible 
that this is due to our large platform and the fact that we 
corrected for multiple comparisons. Additionally, many 
of the studies calculate alcohol consumption using differ-
ent amounts of consumption, use certain g/day cutoffs, or 
another classification method, and as such our results may 
not be directly comparable to others. In a review done by 
Milenkovic et al. on miRNAs and polyphenols, they report 
that the direction of dysregulation of specific miRNAs 
associated with resveratrol in multiple studies varies, and 
they attribute this to differences in cell lines used, resvera-
trol concentrations, and time of resveratrol exposure; this 
finding highlights the potential sensitivity of miRNAs to 
exogenous factors as well as the potential difficulties in 
comparing findings across studies [20]. Finally, while there 
have been studies investigating polyphenol influence on 
miRNA expression for many cancers, there is most often 
one or two studies focusing on any given cancer, some 
using a combination of different polyphenols, which may 
or may not be present in the same foods, and some consider 
a select few miRNAs. Additionally, as some studies use 
animal models, or different human cell lines, these results 
may not be directly comparable. The study whose findings 
most closely matched our own was one that used human 
CRC cells and performed a microarray analysis [43]. We 
encourage others to continue to investigate polyphenol con-
tribution to miRNA expression patterns in disease states, 
particularly CRC, in order to better determine how these 
molecules influence miRNAs and disease states.
In this study, we show that miRNAs are influenced by 
wine consumption. As significant results were found only 
for NRM, it is possible that non-alcoholic components of 
wine alter the normal mucosa and carcinoma tissue of rec-
tal cancer subjects equally and in a manner that contributes 
to the overall dysregulation of genes in CRC.
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